Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical …
Over the last 12 months, insiders at Standard BioTools Inc. have bought $18.49M and sold $0 worth of Standard BioTools Inc. stock.
On average, over the past 5 years, insiders at Standard BioTools Inc. have bought $8.89M and sold $514,009 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Casdin Partners Master Fund, L.P. () — $110.93M.
The last purchase of 250,000 shares for transaction amount of $546,750 was made by Casdin Partners Master Fund, L.P. () on 2024‑08‑27.
2024-08-27 | 250,000 0.0798% | $2.19 | $546,750 | -12.84% | ||||
2024-08-26 | 150,000 0.0471% | $2.15 | $322,455 | -12.44% | ||||
2024-08-23 | 292,100 0.0907% | $2.13 | $620,975 | -11.21% | ||||
2024-08-22 | 307,900 0.088% | $1.96 | $602,807 | -2.31% | ||||
2024-08-21 | 500,000 0.139% | $1.90 | $951,950 | -1.55% | ||||
2024-08-20 | 500,000 0.1368% | $1.87 | $936,700 | +2.96% | ||||
2024-08-19 | 250,000 0.0676% | $1.85 | $463,225 | 0.00% | ||||
2024-08-14 | 1.2M 0.2794% | $1.59 | $1.91M | +22.90% | ||||
2024-08-13 | 550,000 0.13% | $1.62 | $890,560 | +16.56% | ||||
2024-08-12 | 500,000 0.1198% | $1.64 | $820,600 | +19.50% | ||||
2024-08-09 | 525,408 0.1239% | $1.61 | $848,481 | +17.28% | ||||
2024-08-08 | 569,562 0.1362% | $1.64 | $932,601 | +13.47% | ||||
2024-08-07 | 500,000 0.1148% | $1.57 | $786,200 | +19.62% | ||||
2024-08-05 | 200,000 0.0462% | $1.58 | $316,780 | +18.87% | ||||
2024-08-02 | 1M 0.2382% | $1.63 | $1.63M | +14.55% | ||||
2024-05-23 | 100,000 0.038% | $2.60 | $260,000 | -26.05% | ||||
2024-05-22 | 150,000 0.0566% | $2.58 | $387,735 | -25.48% | ||||
2024-05-21 | 350,000 0.1308% | $2.56 | $895,930 | -25.19% | ||||
2024-05-20 | 100,000 0.0377% | $2.58 | $258,130 | -25.19% | ||||
2024-05-17 | 352,072 0.1317% | $2.56 | $902,044 | -24.90% |
Casdin Partners Master Fund, L.P. | 54025821 14.513% | $2.00 | 27 | 0 | +12.56% | |
Caligan Partners LP | 10 percent owner | 11444836 3.0744% | $2.00 | 18 | 0 | <0.0001% |
JOHNSON DAVID EDWARD | 11189663 3.0059% | $2.00 | 8 | 0 | <0.0001% | |
LEVIN CAPITAL STRATEGIES, L.P. | 10 percent owner | 10473809 2.8136% | $2.00 | 111 | 0 | +23.89% |
TORRAY ROBERT E | director | 2381164 0.6397% | $2.00 | 4 | 0 |